Immunic, Inc.
IMUX • NASDAQ • Stock Fundamentals
Immunic, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel Vitt, with a market cap of $178.0M.
Market Cap$178.0M
Employees80.0
CEODaniel Vitt
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 13, 2026 · 1 month 1 day agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Immunic, Inc. FAQ
Common questions about Immunic, Inc.
Immunic, Inc. (IMUX) has a market capitalization of $178.0M and trades on NASDAQ.
Immunic, Inc. has approximately 80 employees.